Search Results
Mar 03, 2026, 17:00 ET Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases
certain haematological cancers. Specifically, ATG-201 is a CD19 targeting bispecific TCE incorporating steric hindrance masking technology, designed to eliminate CD19-expressing B cells. This bispecific interaction with T and B cells through CD3 and CD19 has demonstrated potential in treating B cell-driven
More news about: Antengene Corporation Limited
Mar 03, 2026, 09:48 ET New Research Finds Peanut Butter Consumption Builds Muscle Power in Older Adults
Feb;17(1):e70221. doi: 10.1002/jcsm.70221. PMID: 41632974; PMCID: PMC12867520.Lamb DA, Moore JH, Smith MA, Vann CG, Osburn SC, Ruple BA, Fox CD, Smith KS,Altonji OM, Power ZM, Cerovsky AE, Ross CO, Cao AT, Goodlett MD, Huggins KW,Fruge AD, Young KC, Roberts MD. The effects of
More news about: The Peanut Institute
Mar 03, 2026, 09:18 ET Archipelo and Checkmarx Announce Partnership Connecting AppSec Detection with DevSPM
software creation layer. The platform associates code changes with the developers and AI-assisted workflows that produced them across source control and CI/CD systems. By correlating this activity with security findings, Archipelo supplies attributable origin context — identifying the identity and actions involved
More news about: Archipelo
Mar 03, 2026, 08:01 ET TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients
selectively replicate within both malignant cells and cancer-associated stroma. The virus delivers a multi-cytokine immune-activating payload comprising CD40-L, 4-1BBL, and IL-21, intended to activate dendritic cells, T cells, and NK cells, and to drive a robust, systemic anti-tumor immune response. UIO-524
More news about: TransCode Therapeutics, Inc.
Mar 03, 2026, 07:15 ET ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026
conjugates (ADCs), transforming treatment for patients through our focused portfolio with ZYNLONTA (loncastuximab tesirine-lpyl).ADC Therapeutics' CD19-directed ADC ZYNLONTA received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed
More news about: ADC Therapeutics SA
Mar 03, 2026, 06:00 ET Endor Labs Introduces AURI, Security Intelligence for Agentic Software Development
including Cursor, VS Code, and VSCode, securing AI-generated code without waiting for enterprise rollout. Organizations can then extend AURI across CI/CD pipelines and workflows to deliver consistent security intelligence across the development lifecycle. "The future of software development
More news about: Endor Labs
Mar 02, 2026, 18:25 ET /C O R R E C T I O N -- The Linux Foundation/
Innovation The OCUDU Project is the home to CU and DU open source RAN software; the Ecosystem Foundation and associated assets for CI/CD/CT to establish foundational code base for 5G and early 6G Global industry leaders AMD, AT&T, DeepSig, Ericsson, Nokia, NVIDIA, Softbank
More news about: The Linux Foundation
Mar 02, 2026, 16:05 ET ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
conjugates (ADCs), transforming treatment for patients through our focused portfolio with ZYNLONTA (loncastuximab tesirine-lpyl).ADC Therapeutics' CD19-directed ADC ZYNLONTA received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed
More news about: ADC Therapeutics SA
Mar 02, 2026, 08:30 ET AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease
Defined as decrease in Simple Endoscopic Score for Crohn's disease (SES-CD) >50% from baseline or for patients with isolated ileal disease and a baseline SES-CD of 4, at least a 2-point reduction from baseline, as scored by blinded central reviewer at week 12.1
More news about: AbbVie
Mar 02, 2026, 08:13 ET FTC Warns PBM Practices Are Driving Higher Drug Costs and Employers Start to Push Back
t-managers AP News (Apr. 2025): Arkansas bans pharmacy benefit managers from owning pharmacies in state. apnews.com/article/9e2449a2ac7f7aa206cd49f9211447b3 Axios (Jun. 9, 2025): PBM trade group sues Arkansas over pharmacy law. axios.com/2025/06/09/arkansas-pharmacy-law-pbm PharmaVoice (Jun.
More news about: US-Rx
Mar 02, 2026, 06:55 ET Sealed Air Reports Q4 and Full Year 2025 Results
operations as reported.CD&R Acquisition UpdateAs announced on November 17, 2025, Sealed Air has entered into a definitive agreement to be acquired by funds affiliated with CD&R, a leading private investment firm with deep experience in the industrial
More news about: Sealed Air
Mar 01, 2026, 19:30 ET XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
x CD3 (ATG-201 for B cell-related autoimmune diseases), CDH6 x CD3 (ATG-106 for ovarian cancer and kidney cancer), ALPPL2 x CD3 (ATG-112 for gynecologic tumors and non-small cell lung cancer), LY6G6D x CD3 (ATG-110 for microsatellite-stable colorectal cancer), GPRC5D x CD3 (ATG-021 for multiple
More news about: Antengene Corporation Limited
Feb 27, 2026, 09:46 ET Department of the Air Force Awards $8.6M to Istari Digital for Industry Øne
time. By treating data as a place to compute rather than a file to move, the infrastructure supports Continuous Integration and Continuous Deployment (CI/CD), automated verification, and trusted cross-organizational collaboration at industrial scale.What it delivers. Industry Øne represents
More news about: Istari Digital, Inc.
Feb 27, 2026, 08:45 ET Independent Hip-Hop Artist Bob "B-Cide" Cardillo to Release Concept Album MonSter on March 1, 2026
streaming availability on platforms such as Spotify, Apple Music, and Amazon Music, the album will be issued in multiple physical formats including CD, cassette, USB limited edition, and vinyl. The multi-format rollout reinforces B-Cide's belief in ownership, tangible collectibles, and long-term catalog
More news about: Robert "B-Cide" Cardillo
Feb 26, 2026, 14:30 ET Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer
Pasritamig is designed to engage the immune system through a novel mechanism of action, binding CD3 on T cells and human kallikrein 2 (KLK2). KLK2 is a novel, highly specific prostate cancer target with minimal expression outside prostate tissue. By
More news about: Johnson & Johnson
Feb 26, 2026, 09:48 ET 再鼎醫藥公佈2025年第四季度及全年財務業績和近期公司進展
推進具有差異化優勢的全球管線，包括ZL-1503（IL-13/IL-31Rα）、ZL-6201（LRRC15 ADC）、ZL-1222（PD-1/IL-12）和ZL-1311（MUC17/CD3 TCE）– 持續推進關鍵區域性項目，KarXT在中國獲批並已啟動商業化上市籌備工作；
More news about: 再鼎醫藥
Feb 26, 2026, 09:00 ET VITURE Starts 2026 Strong with Another $100M Raise, Surpassing $200M in Six Months
serve as a cornerstone of VITURE's 2026 roadmap.Cultural Momentum: Cyberpunk CollaborationIn December, VITURE partnered with CD Projekt RED to release a serialized limited-edition XR collaboration celebrating the fifth anniversary of Cyberpunk 2077.
More news about: VITURE
Feb 26, 2026, 09:00 ET Índice de amenazas IBM 2026 X-Force: los ataques impulsados por IA se intensifican a medida que las brechas de seguridad básicas dejan a las empresas expuestas
cadenas de suministro o de terceros desde 2020, impulsado principalmente por atacantes que explotan las relaciones de confianza y la automatización de CI/CD en flujos de trabajo de desarrollo e integraciones de SaaS. Se espera que la presión sobre los pipelines y los ecosistemas de código abierto aumente
More news about: IBM
Feb 26, 2026, 08:35 ET Llamadas con IA: Creando una red de voz orientada al futuro
los 80 millones, con una base de usuarios en constante expansión. Más de 70 modelos de terminales admiten ahora la funcionalidad de canal de datos (CD). China Mobile ha introducido un asistente de vida con inteligencia artificial que ofrece numerosos servicios a través de llamadas, como consultas médicas
More news about: Huawei
Feb 26, 2026, 08:00 ET Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™
has been achieved. If neutrophil engraftment failure occurs in a patient treated with LYFGENIA, provide rescue treatment with the back-up collection of CD34+ cells.Insertional OncogenesisThere is a potential risk of lentiviral vector-mediated insertional oncogenesis after treatment
More news about: Orsini
Feb 26, 2026, 05:00 ET CD&R Foundation Supports Three Non-Profits in Latest Grants to Advance Economic Opportunity and Employment in UK
/PRNewswire/ -- CD&R ("CD&R" or the "Firm") today announced that the CD&R Foundation (the "Foundation") has made grants totalling £1.3 million to three UK non-profit organisations, which will be disbursed over the next three years. These organisations, identified as CD&R's Talent Solution
More news about: CD&R
Feb 26, 2026, 05:00 ET CD&R Foundation Supports Three Non-Profits in Latest Grants to Advance Economic Opportunity and Employment in UK
/PRNewswire/ -- CD&R ("CD&R" or the "Firm") today announced that the CD&R Foundation (the "Foundation") has made grants totalling £1.3 million to three UK non-profit organisations, which will be disbursed over the next three years. These organisations, identified as CD&R's Talent Solution
More news about: CD&R
Feb 25, 2026, 20:00 ET Atomos Announces Ninja RAW 5.2" HDMI HDR Monitor-Recorder; More Info at B&H
Codecs PreloadedLocking HDMI 2.0 Input/OutputRecords to CFexpress Type B Slot, USB-COptional USB-C Network Adapter1500 cd/m² BrightnessCapture up to 6K30 ProRes RAW VideoUpdated AtomOS Linux Operating SystemL-Series Battery Slot, Tally LightThere's
More news about: B&H Photo
Feb 25, 2026, 16:15 ET Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase
Registered: 075887CE7144A: 075887CD9Reg S:U0740RAE2
More news about: BD (Becton, Dickinson and Company)
Feb 25, 2026, 16:15 ET FS KKR Capital Corp. Announces Fourth Quarter and Full Year 2025 Results; Declares First Quarter 2026 Distribution of $0.48 per Share
https://register-conf.media-server.com/register/BI39e404f22c094c9aa787cd75ff19a5f6. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference
More news about: Future Standard